Scholarly EP027 - SpineX's Neuromodulation for Incontinence with Dr. Parag Gad

Join us this episode for a conversation with Dr. Parag Gad, co-founder and CEO of SpineX, for a conversation about the Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder, or the SCONE “CONTINENCE” Clinical trial (https://www.clinicaltrials.gov/study/NCT05301335). Dr. Gad talks gives a brief history on SpineX, the scientific inspiration for the current neuromodulation trial targeting incontinence, and visions for the company's future commercial targets. This episode on a neuromodulatory device targeting urinary function was recorded in collaboration with our friends at Bladder Buzz, (in our opinion) the podcast on neurogenic bladder that "brings together physicians, researchers, and individuals living with neurogenic bladder" (https://bladderbuzzpodcast.buzzsprout.com/). We hope you enjoy this collab episode with Dr. Gad from SpineX.

Om Podcasten

The American Spinal Injury Association (ASIA) brings you SCI Science Perspectives. The podcast is built around two-part dialogues with spinal cord injury (SCI) professionals regarding their emerging scientific work spanning the full spectrum of SCI research, from discovery to clinical application. The SCI Science Perspectives podcast disseminates the latest-and-greatest scientific work in the SCI field via a conversation with researchers that approaches their work from two perspectives: the “scholarly” perspective and the “community” perspective. The process begins with ASIA’s Committees informing the podcast about new and influential scientific papers relevant to the committee’s interests. Then the podcast host(s) then interview the author(s) of the papers, approaching their project from each perspective. Finally, the conversation from each perspective is published as its own episode type: "Scholarly" and "Community" episodes. Keep an eye out too for "Admin" episodes too, communicating administrative information relevant to ASIA members and stakeholders.